Fermented foods: greater diversity was not the only trial readout
Wastyk’s randomized study compared diet-specific microbiome and immune responses, not clinical disease prevention.

Illustrative food image, not a photograph of the study intervention.
Two dietary strategies, eighteen people per arm
The 2021 Wastyk study used a 17-week randomized prospective design to compare plant-based high-fiber and high-fermented-food diets in healthy adults, with 18 participants per arm. Researchers combined microbiome measurements with extensive immune profiling rather than recording only one bacterial count. This setup matters because the diets were intended to influence both microbial features and host responses. It was nevertheless a small study in healthy adults. The abstract does not describe a trial treating inflammatory bowel disease, and its immune measurements should not be confused with observed prevention or remission of a clinical disease.
Wastyk HC, Fragiadakis GK, Perelman D, et al.. Cell 184:4137–4153.e14, 2021. PMID 34256014 · DOI
Fermented foods changed two kinds of markers
The high-fermented-food diet steadily increased microbiota diversity and decreased inflammatory markers. These are the headline findings for that dietary arm, but the abstract does not provide a numerical diversity effect or list the size of each inflammatory-marker change. It also does not establish that one particular fermented ingredient caused the response. The comparison therefore supports a result for the studied dietary strategy, not a guaranteed benefit from every fermented food. Diversity and inflammatory-marker measurements are informative endpoints; neither is equivalent to a count of illnesses avoided or symptoms resolved during the study.
Wastyk HC, Fragiadakis GK, Perelman D, et al.. Cell 184:4137–4153.e14, 2021. PMID 34256014 · DOI
Fiber did not simply fail
The high-fiber diet increased microbiome-encoded glycan-degrading carbohydrate-active enzymes even though microbial community diversity remained stable. The cytokine response score, identified as the primary outcome, was unchanged. Researchers also identified three distinct immunological trajectories among high-fiber consumers that corresponded to baseline microbiota diversity. These findings make a simple winner-and-loser interpretation misleading. A stable diversity measure did not mean that the microbiome showed no response, and the primary immune result deserves mention alongside the fermented-food findings. The study illustrates why different microbial and immune measurements should be described separately rather than collapsed into a single gut-health score.
Wastyk HC, Fragiadakis GK, Perelman D, et al.. Cell 184:4137–4153.e14, 2021. PMID 34256014 · DOI
A whole dietary arm is not a recipe test
The abstract does not isolate a vegan fermented-food intervention or test the linked tempeh dish. That recipe is a thematic accompaniment, not evidence that a cooked serving will reproduce the microbiome or immune changes. The study also cannot establish long-term clinical benefit from its small, 17-week comparison. Its disclosures list founder and shareholder relationships for several investigators, including relationships with biotechnology companies; these belong in the interpretation without assuming that they invalidate the results. The defensible conclusion is specific: the two dietary strategies produced different microbiome and immune readouts in this group of healthy adults.
Wastyk HC, Fragiadakis GK, Perelman D, et al.. Cell 184:4137–4153.e14, 2021. PMID 34256014 · DOI